Prodromal Alpha-Synuclein Screening in Parkinson's Disease Study

Abroad (travel likely)Recruiting

Conditions

Parkinson Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Department for Neurology, University of Kiel, Kiel, Germany
Contact: Study coordinator (Eva Schäffer, Dr.) · eva.schaeffer@uksh.de · 004943150023983

Study leads

Daniela Berg, Prof.Dr.
Principal Investigator
Department for Neurology, University of Kiel

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease

Parkinson Disease

Abroad (travel likely)RecruitingPHASE2

Davie, United States · Hialeah, United States

Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation

Parkinson Disease

Abroad (travel likely)Recruiting

Ann Arbor, United States

Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging)

Parkinson Disease

Abroad (travel likely)RecruitingEARLY_PHASE1

Birmingham, United States

Exercise Management in Parkinson's Disease

Parkinson Disease (PD)

Abroad (travel likely)Recruiting

Maltepe, Turkey (Türkiye)